US-based medical device outsources (MDO) manufacturer Integer Holdings has acquired Inomec, Israel-based medical device development and manufacturing firm.

Financial details are yet to be disclosed by either company.

The acquisition will provide Texas-based Integer with research and development, as well as a sales centre in Israel, expected to strengthen the company’s portfolio with the addition of catheter design, clinical, and pilot manufacturing capabilities.

Integer president and CEO Joe Dziedzic said: “Acquiring Inomec strengthens our research and development pipeline by adding differentiated capabilities and expanding our global footprint in a key market with an extensive innovation ecosystem that is widely recognized as a leader in MedTech innovation.”

Inomec, set up in 2008, is involved in research, development and manufacturing of medical devices including metal implants, minimally invasive tools, delivery systems, laser processing services and drug-device combination devices.

Bio-compatible 3D printing, clinical and pilot manufacturing, polymer and metallic laser welding, and cleanroom assembly and packaging services are among the capabilities of Inomec.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Inomec in Israel is expected to become a significant research and development centre, alongside Plymouth and Chaska in Minnesota, Clarence in New York, Beaverton Oregon, Raynham, Massachusetts, Montevideo, Uruguay, and Galway, Ireland.

The centre will allow Integer inclusion in a pipeline of early and late-stage startups, as well as multinational medical device technology firms in Israel.

It will offer added research and development capabilities to Integer’s other manufacturing facilities across the world.

It focuses on markets such as cardiac, vascular, portable medical, neuromodulation, advanced surgical and orthopaedics, also producing batteries for high-end niche applications in energy, military, and environmental markets.